Research
Energy balance
GLP-1 receptor agonist use was associated with a higher risk of discontinuation of endoscopy compared to SGLT-2 inhibitors.
Practitioners should be aware of the increased risk of endoscopy discontinuation when using GLP-1 receptor agonists.
StrongSupportsmedium confidence
GLP-1 receptor agonists were associated with a higher risk of discontinuation of endoscopy (1.99, 1.56 to 2.53).
Why this rating
Based on the cohort study design.
Source
Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study
Wajd Alkabbani et al. · BMJ · 2024
DOI 10.1136/bmj-2024-080340
cohort · n=43365Cited 51×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →